ATB

ncRNA information

ncRNA name

ATB

Specific or universal ncRNAs

Specific ncRNAs

Class

Long noncoding RNA

Biomarker

None

Biomarker application

Upstream regulatory factors

Not available

Downstream target

miR-200a

Cancer information

Cancer name

Lung Adenocarcinoma

Cancer site

qRT-PCR,Western blot,Luciferase assay

Treatment information

Treatment type

Chemotherapy

Drug

Cisplatin

Impact of wild-type ncRNA on chemotherapy resistance

Up

Impact of knockdown of ncRNA on chemotherapy resistance

Impact of overexpression of ncRNA on chemotherapy resistance

Clinical Information

ncRNA differential expression in
cancer patients vs. healthy people

Not available

Number of patients

Not available

Male patients

Not available

Female patients

Not available

Age range and number

Not available

Research information

PMID

Description

LncRNA-ATB Promotes Cisplatin Resistance in Lung Adenocarcinoma Cells by Targeting the miR-200a/Ī²-Catenin Pathway

Tissue resource

human lung adenocarcinoma cell lines A549

human lung adenocarcinoma cell lines H1975

human lung adenocarcinoma cell lines A549/CDDP

Experiment

None


Institute

Cell Bank of Type Culture Collection of Chinese Academy of Sciences

Country

Continent